A crucial step in the life cycle of many viruses is the proteolytic processing of viral and cellular proteins (6) . This is especially evident with certain picornaviruses which encode proteinases which not only process viral proteins but also carry out specific and controlled proteolysis of the eukaryotic initiation factor 4GI (eIF4GI) and its isoform 4GII (11, 20, 27) . These proteins are components of the eIF4F complex, which is responsible for recruitment of capped mRNA to the ribosome (19) . Cleavage of the eIF4G isoforms prevents recruitment of capped mRNAs, thus disabling host cell protein synthesis. Picornaviral mRNAs can, however, still be translated under these conditions, since protein synthesis initiates at a higherordered structure, termed the internal ribosome entry site, within the 5Ј untranslated region (2) .
Picornaviruses have evolved two different types of proteinases for cleavage of the eIF4G isoforms (23) . Foot-and-mouth disease virus (FMDV) encodes a papain-like cysteine proteinase, the leader proteinase (L pro ), at the very N terminus of the polyprotein (10, 12) . L pro frees itself from the polyprotein by cleavage between its own C terminus and the adjacent protein, VP4 (26) . Proteolysis of eIF4GI by L pro has recently been shown to be enhanced by an apparently direct interaction of the C-terminal extension (CTE) of L pro with the eIF4G isoforms (7) .
In contrast, human rhinoviruses (HRVs) and enteroviruses (polioviruses and coxsackieviruses) encode a different cysteine proteinase, namely the 2A proteinase (2A pro ), which is responsible for cleavage of the eIF4G isoforms (17, 23) . This enzyme differs from the majority of cysteine proteinases by possessing a chymotrypsin fold as well as containing zinc (22, 25) . The zinc ion, located about 20 Å from the active site, appears not to play a role in catalysis; instead, it has been proposed to play a structural role, possibly taking over the role of a disulfide bridge found at an equivalent position in extracellular chymotrypsin-like proteinases (22, 28) . 2A pro is located toward the center of the viral polyprotein and processes itself from the growing polypeptide chain by cleavage between the C terminus of the preceding protein, VP1, and its own N terminus. Processing at the C terminus of 2A pro is carried out by the second viral proteinase, 3C
pro . Despite much investigation, the mechanism of cleavage of eIF4G isoforms by human rhino-and enteroviral 2A pro is still not completely understood. Evidence for direct cleavage of eIF4GI by 2A pro from poliovirus, coxsackievirus B4, and HRV2 has been shown (3, 15, 16, 29) . In contrast, cleavage of eIF4GI during poliovirus infection appears to occur indirectly via activation of cellular proteinases as well as by 2A pro (32, 33) .
We have previously investigated in detail the relationship between FMDV L pro self-processing and its ability to cleave eIF4GI. eIF4GI proteolysis was independent of whether the L pro was expressed as a mature protein or whether it was expressed as a polyprotein with subsequent VP4/VP2 sequences. Indeed, inhibition of L pro self-processing by mutation of the cleavage site between L pro and VP4 did not inhibit eIF4GI processing (8) . Finally, the onset of eIF4GI cleavage was rapid and occurred at low concentrations; proteolysis of eIF4GI could be observed even before mature L pro was detectable by fluorography (8, 9) . HRV2 2A pro is not active immediately after synthesis. In contrast to L pro , when mature HRV2 2A pro was expressed in rabbit reticulocyte lysates (RRLs), cleavage of eIF4GI did not begin until at least 10 min after synthesis of 2A pro had been initiated (9) . To investigate whether self-processing also did not commence until this time, we constructed a plasmid (pHRV2 VP1-2A pro ) encoding the HRV2 VP1 and 2A pro (HRV2 nucleotides 2318 to 3586 cloned downstream of the encephalomyocarditis virus internal ribosome entry site in the plasmid pCITE), enabling us to examine HRV2 2A pro selfprocessing between the C terminus of VP1 and its own N terminus. Following linearization with BamHI, mRNA was transcribed in vitro as described previously (9) from pHRV2 VP1-2A pro and translated in vitro in RRLs. In vitro translation reactions (typical volume, 50 l) contained 70% RRL (Promega), 20 Ci of [
35 S]methionine (1,000 Ci/mmol; Hartmann Analytic), 0.8 U of RNasin/l, and unlabeled amino acids except methionine at 20 M. After preincubation for 2 min at 30°C, translation was started by addition of mRNA to a final concentration of about 10 ng/l. Samples were taken at different time points and placed on ice; unlabeled methionine and cysteine were then added to a 2 mM concentration (each) followed by Laemmli sample buffer. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (PAGE) and examined as described previously (8, 9) either by fluorography to detect the radiolabeled translation products (Fig. 1A) or by immunoblotting with an antibody against the N terminus of eIF4GI to monitor the status of the endogenous eIF4GI in the RRL (Fig. 1B) .
The unprocessed precursor protein VP1-2A pro has a molecular mass of 49 kDa, while those of the processed products VP1 and 2A pro are 33 and 16 kDa, respectively. The 10-min time point (Fig. 1A , lane 2) shows more than 90% unprocessed VP1-2A pro , indicating that in contrast to FMDV L pro , 2A pro is not immediately active upon synthesis. Complete cleavage is achieved between 60 and 90 min. The amounts of VP1 decrease over time, indicating nonspecific degradation of the protein in the lysate; this has been observed for certain proteins expressed in RRLs (21) . The band corresponding to 2A pro is less intense than VP1, since it contains only two methionines, compared to the 9 methionines of VP1. To compare the effect of self-processing on eIF4GI cleavage, RNA from a plasmid encoding mature 2A pro without VP1 was also synthesized and translated ( Fig. 1, lanes 12 to 14) . The mature 2A pro in this construction is preceded by five additional amino acids from pCITE (MetAlaThrThrMet); therefore, the 2A pro has four methionines compared to the two present in 2A pro after processing from VP1. Thus, the intensity of the respective bands is about double.
The time course cleavage of eIF4GI is shown in Fig. 1B . Intact eIF4GI runs as a series of bands around 220 kDa due to microheterogeneity at the N terminus, while the N-terminal cleavage products of eIF4GI generated by 2A pro cleavage migrate at around 140 kDa. At the 10-min time point (Fig. 1B,  lane 2) , essentially no eIF4GI cleavage has occurred; once initiated, cleavage is rapid, being almost complete after 30 min. Similar rates of eIF4GI cleavage were observed in the absence of self-processing with 2A pro alone (lanes 12 to 14). Thus, independent of whether self-processing of HRV2 2A pro takes place or not, and in contrast to FMDV L pro , 2A pro appears not to be immediately active upon synthesis but rather requires time to gain activity. In addition, the presence of the VP1 sequence appears to have no effect at the rate at which 2A pro gains activity.
The VP1-2A pro precursor cannot cleave eIF4GI. To further investigate the relationship between the two cleavage reac- tions, we decided to inhibit self-processing by mutating the VP1-2A pro cleavage site. We demonstrated previously in a bacterial system (24) that replacement of the P1Ј site amino acid glycine by a tryptophan completely prevents self-processing. Therefore, using standard methods of PCR mutagenesis, we constructed a variant of VP1-2A pro in which the first amino acid of 2A pro , glycine, was replaced by a tryptophan (pHRV2 VP1-2A pro G1W). mRNA from this plasmid was then translated in vitro in RRLs, and the effect on eIF4GI cleavage was monitored (Fig. 1, lanes 6 to 9) . As shown in Fig. 1A , only the unprocessed precursor protein is observed, confirming that 2A pro can no longer process itself from VP1. Interestingly, the failure to process VP1 from 2A
pro also results in a lack of eIF4GI cleavage (Fig. 1B) ; even after 90 min of incubation, no significant eIF4GI cleavage by VP1-2A pro G1W was seen. To rule out any effect of this mutation on the catalytic activity of 2A pro , we translated an mRNA encoding the 2A pro G1W protein without VP1. This variant showed normal eIF4GI cleavage rates (data not shown). Thus, although it contains a potentially catalytically active enzyme, the uncleaved VP1-2A pro precursor has essentially almost no ability to process eIF4GI. This is in contrast to FMDV L pro , which can still cleave eIF4GI even when self-processing is inhibited by mutations introduced at the cleavage site (8) .
What are the molecular mechanisms behind these differences between 2A pro and L pro ? Examination of the threedimensional structures of the two enzymes reveals a clear difference between the lengths and conformations of the termini at which processing occurs. Thus, L pro has a C-terminal extension of 18 amino acids which projects well away from the main globular domain and lies about 30 to 40 Å from the active site. This suggests that the CTE can move away from the active site, leaving it available for other substrates. In contrast, the N terminus of HRV2 2A pro is closer to the active site, and only five amino acids of the N terminus project away from the globular domain; this suggests that the uncleaved VP1 protein blocks the enzyme's active site, thus preventing access to other substrates.
TPEN, a zinc chelator, prevents acquisition of an active conformation by HRV2 2A pro . The delay in onset of 2A pro cleavage of both self-processing and eIF4GI cleavage suggested that the enzyme was initially synthesized in an inactive form. Since HRV 2A pro is known to contain zinc (25, 30), we decided to investigate whether the incorporation of the zinc ion into the enzyme was rate limiting by removal or addition of zinc to the lysate. We used the highly specific zinc chelator N,N,NЈ,NЈ-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN) (Sigma). TPEN has a very high specificity for Zn 2ϩ (pK a ϭ 15.4) but low affinities for Ca 2ϩ (pK a ϭ 3) and Mg 2ϩ (negligible) (4). The effects of zinc depletion on HRV2 2A pro activity were assayed by preincubating the RRL with different concentrations of TPEN (dissolved in ethanol at a stock concentration of 25 mM and diluted with water to the appropriate concentration immediately before use) before adding the VP1-2A pro mRNA. Figure 2A and B show that increasing concentrations of TPEN inhibit 2A pro self-processing and eIF4GI-processing ability. At 5 M TPEN, 50% self-processing and eIF4GI cleavage are observed at 60 min, whereas the control shows 50% cleavage at 30 min and almost complete cleavage at 60 min (compare Fig. 2 , lanes 5 and 6 with Fig. 1, lanes 3 and 4) . In contrast, the addition of zinc in the absence of TPEN does not influence 2A pro activity in any way (Fig. 2, lanes 7 to 9) . This suggests that the endogenous zinc concentration in the RRL is sufficient for 2A pro activity, despite the presence of the very (25, 30) have shown that HRV2 2A pro binds the zinc very tightly. The zinc cannot be extracted by 10 mM EDTA; removal of the zinc from HRV2 2A pro was achieved only after denaturation. The zinc-depleted denatured enzyme could be reactivated by renaturation in the presence of zinc. We were interested whether the de novo synthesized protease could be activated by addition of zinc without any special denaturation and renaturation steps. Therefore, it was necessary to completely inhibit HRV2 2A pro ; this was achieved by translating the VP1-2A pro mRNA in the presence of 10 M TPEN ( Fig. 2C and D, lanes 11 and 12) . After 30 min, cycloheximide was added to a concentration of 10 ng/l to stop the synthesis of new 2A pro (Fig. 2, lane 12) . At 35 min, we added either ZnCl 2 to a 10 M concentration to activate the 2A pro or CaCl 2 as a control to the reaction mix and continued the incubation (Fig. 2, lanes 13 to 17) . The presence of 10 M TPEN inhibits 2A pro almost completely, since after 65 min without ZnCl 2 (Fig. 2, lane 17) essentially no self-processing or eIF4GI cleavage is observed. In contrast, just 10 min after addition of 10 M ZnCl 2 (Fig. 2, lane 14) , both VP1-2A pro and eIF4GI cleavage had reached about 50%. The absence of the previously observed 10-min delay indicates that the incorporation of zinc into de novo-synthesized VP1-2A pro is a very rapid step.
It is worth noting that neither the addition of TPEN nor that of zinc (both compounds were tested at 5 M) affected L pro activity in any way, showing that the effect is specific to HRV2 2A pro (data not shown). TPEN can protect HeLa cells from the viral cytopathic effect. Since the presence of TPEN can prevent the activation of de novo synthesized HRV2 2A pro , we investigated whether TPEN can be used to block HRV replication in cell culture. TPEN is able to permeate membranes and thus ideally suited for this purpose. To examine any possible differences between minor and major group HRVs, both HRV2 and HRV14 were used. HeLa cells were incubated with different concentrations of TPEN, and the cells were infected with HRV2 or HRV14 or incubated with medium alone. The viability of the cells was then assayed after 24 h using the Cell Titer 96 AQ ueous nonradioactive cell proliferation assay (Promega). Briefly, 10 6 cells were seeded into a 96-well plate 1 day prior to infection. Cells were infected using HRV serotypes 2 and 14 at 20 50% tissue culture infective doses/cell in the presence or absence of the indicated TPEN concentrations. Each experiment was repeated three times. Twenty-four hours after infection, cell viability was determined by adding the tetrazolium compound followed by incubation for 2 h at 37°C and subsequent measurement of absorption at 492 nm in a Labsystems Multiscan RC plate reader. Figure 3 shows that uninfected HeLa cells remain viable in the presence of TPEN up to concentrations between 1.25 and 1.8 M. Higher TPEN concentrations are increasingly cytotoxic. The cytotoxic effect of TPEN is not unexpected, since depletion of zinc in HeLa cells leads to activation of specific caspases which then induce apoptosis (5, 13, 18) . The concentrations of TPEN at which apoptosis was induced were very similar to those reported previously (18) .
Despite the loss of cell viability due to the induction of apoptosis by TPEN, protection of cells from viral infection was observed at TPEN concentrations between 1.8 M and 2.5 M (Fig. 3) . With HRV14 (Fig. 3B) , the protection was more pronounced, with 60% of cells protected at a concentration of 1.25 M, a concentration below that required for inducing apoptosis. Thus, the inhibition of HRV infection with a potent zinc chelator is feasible.
It has been known for many years that the addition of zinc itself inhibits HRV replication. The mechanism of this inhibition remains unclear, but it appears to involve binding of zinc to the part of the polyprotein containing the capsid precursors (14) . In contrast, we have shown that inhibition of replication of two serotypes could be achieved by the chelation of zinc, brought about by the presence of TPEN. Although chelation of zinc by TPEN induces apoptosis, a concentration range was found which protected cells to a significant extent against infection by both HRV2 and HRV14. Notably, the concentration range of 1.5 to 2 M is clearly lower than the 10 M required for 2A pro inhibition in RRLs. This implies either that the zinc concentration is lower in HeLa cells than in RRLs or that TPEN is also affecting other cellular processes. Since TPEN has been shown to interfere with endocytosis (1), it seems possible that viral entry may also be affected. The rapid induction of apoptosis by TPEN in HeLa cells would seem to preclude its use as a possible antiviral compound. However, other cell types, such as macrophages, have been shown to remain unaffected by TPEN concentrations as high as 150 M (1). Thus, future work will be directed towards determining the TPEN sensitivities of cell lines capable of supporting HRV replication. An investigation of the usefulness of TPEN and related zinc chelators as inhibitors of HRV and human enterovirus replication can then be made with the cell lines most resistant to TPEN. Furthermore, it will be of interest to examine whether TPEN can also inhibit the replication of polio-and coxsackieviruses. Although the 2A pro s of these viruses have not been directly shown to contain zinc, site-directed mutagenesis and amino acid alignments (31) strongly imply the ability of these proteinases to bind zinc and thus their sensitivity to TPEN during viral replication.
